Skip to main content
Top
Published in: Rheumatology International 7/2019

01-07-2019 | Granulomatosis with Polyangiitis | Cases with a Message

Urethral involvement in granulomatosis with polyangiitis: a case-based review

Authors: Hamdy M. A. Ahmed, Mohanad M. Elfishawi, Ahmed Hagiga, Ibrahim M. A. Ahmed, Ya Li Chen

Published in: Rheumatology International | Issue 7/2019

Login to get access

Abstract

Granulomatosis with polyangiitis (GPA) commonly presents with glomerulonephritis and inflammation of upper and lower respiratory tracts. It can also involve other organs including those of the urinary tract. The involvement of the urethra is very rarely reported. We present a case of GPA in a patient who had recurrent urinary tract infections and an acute bladder outlet obstruction due to a urethral thickening by GPA. In this report, we discuss urethral involvement with GPA. The incidence of such involvement, as with other urinary tract organs, might be underestimated. It can affect both sexes, with male predominance, and can occur at any age. It responds to standard GPA medical treatment but may require surgical intervention. Rheumatologists should be aware of this limited form of GPA as early recognition and treatment can decrease the risk of complications.
Literature
5.
go back to reference Reinhold-Keller E, Beuge N, Latza U, De Groot K, Rudert H, Nölle B et al (2000) An interdisciplinary approach to the care of patients with Wegener’s granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 43(5):1021–1032CrossRefPubMed Reinhold-Keller E, Beuge N, Latza U, De Groot K, Rudert H, Nölle B et al (2000) An interdisciplinary approach to the care of patients with Wegener’s granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 43(5):1021–1032CrossRefPubMed
6.
go back to reference Group TWR (2002) Design of the Wegener’s granulomatosis etanercept trial (WGET). Control Clin Trials 23(4):450–468CrossRef Group TWR (2002) Design of the Wegener’s granulomatosis etanercept trial (WGET). Control Clin Trials 23(4):450–468CrossRef
8.
go back to reference Schnabel A, Holl-Ulrich K, Dalhoff K, Reuter M, Gross WL (1997) Efficacy of transbronchial biopsy in pulmonary vaculitides. Eur Respir J 10(12):2738–2743CrossRefPubMed Schnabel A, Holl-Ulrich K, Dalhoff K, Reuter M, Gross WL (1997) Efficacy of transbronchial biopsy in pulmonary vaculitides. Eur Respir J 10(12):2738–2743CrossRefPubMed
12.
go back to reference Huong DL, Papo T, Piette JC, Wechsler B, Bletry O, Richard F et al (1995) Urogenital manifestations of Wegener granulomatosis. Medicine (Baltimore). 74(3):152–161CrossRefPubMed Huong DL, Papo T, Piette JC, Wechsler B, Bletry O, Richard F et al (1995) Urogenital manifestations of Wegener granulomatosis. Medicine (Baltimore). 74(3):152–161CrossRefPubMed
15.
go back to reference Fowler M, Martin SA, Bowles WT, Packman R, Katzenstein A-L (1979) Wegener granulomatosis Unusual cause of necrotizing urethritis. Urology 14(1):66–69CrossRefPubMed Fowler M, Martin SA, Bowles WT, Packman R, Katzenstein A-L (1979) Wegener granulomatosis Unusual cause of necrotizing urethritis. Urology 14(1):66–69CrossRefPubMed
16.
go back to reference Jensen KE, Nielsen K, Kock K (1982) Necrotising urethritis in Wegener’s granulomatosis. Br J Urol. 54(4):434CrossRef Jensen KE, Nielsen K, Kock K (1982) Necrotising urethritis in Wegener’s granulomatosis. Br J Urol. 54(4):434CrossRef
17.
go back to reference Dore B, Duriez P, Grange P, Aubert J (1990) Wegener’s granulomatosis with urethral-penile location: Apropos of a case. Ann Urol 24(3):256–258 Dore B, Duriez P, Grange P, Aubert J (1990) Wegener’s granulomatosis with urethral-penile location: Apropos of a case. Ann Urol 24(3):256–258
18.
go back to reference Weiss R, Hrehorovich V (1991) An unusual manifestation of Wegener’s granulomatosis. Md Med J (Baltimore, Md: 1985) 40(4):271 Weiss R, Hrehorovich V (1991) An unusual manifestation of Wegener’s granulomatosis. Md Med J (Baltimore, Md: 1985) 40(4):271
19.
go back to reference Ter Maaten J, Franssen C, Daenekindt A, Hoorntje S (1993) Triple Wegener’s granulomatosis in the urogenital tract. Nephron 63(3):358–359CrossRefPubMed Ter Maaten J, Franssen C, Daenekindt A, Hoorntje S (1993) Triple Wegener’s granulomatosis in the urogenital tract. Nephron 63(3):358–359CrossRefPubMed
20.
go back to reference Zielonka T, Madalinska M, Droszcz W, Pogorzelski R, Borkowski A (1995) Urethral stricture as unusual complications of Wegener’s granulomatosis. Neth J Med 46(5):236–238CrossRefPubMed Zielonka T, Madalinska M, Droszcz W, Pogorzelski R, Borkowski A (1995) Urethral stricture as unusual complications of Wegener’s granulomatosis. Neth J Med 46(5):236–238CrossRefPubMed
21.
go back to reference Linehan J, Bhakri H (1995) Penile granulomas with urethral stricture: unusual presentation of Wegener’s granulomatosis. Br J Clin Pract 49(1):47PubMed Linehan J, Bhakri H (1995) Penile granulomas with urethral stricture: unusual presentation of Wegener’s granulomatosis. Br J Clin Pract 49(1):47PubMed
22.
go back to reference Ebo D, Mertens A, De Clerck L, Gentens P, Daelemans R (1998) Relapse of Wegener’s granulomatosis presenting as a destructive urethritis and penile ulceration. Clin Rheumatol 17(3):239–241CrossRefPubMed Ebo D, Mertens A, De Clerck L, Gentens P, Daelemans R (1998) Relapse of Wegener’s granulomatosis presenting as a destructive urethritis and penile ulceration. Clin Rheumatol 17(3):239–241CrossRefPubMed
23.
go back to reference Sharma A, Gopalakrishan D, Nada R, Kumar S, Dogra S, Aggarwal MM et al (2014) Uncommon presentations of primary systemic necrotizing vasculitides: the Great Masquerades. Int J Rheum Dis 17(5):562–572CrossRefPubMed Sharma A, Gopalakrishan D, Nada R, Kumar S, Dogra S, Aggarwal MM et al (2014) Uncommon presentations of primary systemic necrotizing vasculitides: the Great Masquerades. Int J Rheum Dis 17(5):562–572CrossRefPubMed
25.
go back to reference Anderson PT, Gottheil S, Gabril M, Barra L, Power N (2017) Acute urinary retention secondary to urethral involvement of granulomatosis with polyangiitis. Can Urol Assoc J 11(1–2):E38CrossRefPubMedPubMedCentral Anderson PT, Gottheil S, Gabril M, Barra L, Power N (2017) Acute urinary retention secondary to urethral involvement of granulomatosis with polyangiitis. Can Urol Assoc J 11(1–2):E38CrossRefPubMedPubMedCentral
26.
go back to reference Nielsen K, Jensen K, Kock K (1981) Wegener’s granulomatosis. A brief review and report of an unusual course with urethral localization. Ugeskrift for laeger 143(16):1003PubMed Nielsen K, Jensen K, Kock K (1981) Wegener’s granulomatosis. A brief review and report of an unusual course with urethral localization. Ugeskrift for laeger 143(16):1003PubMed
27.
go back to reference Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD et al (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116(6):488–498CrossRefPubMed Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD et al (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116(6):488–498CrossRefPubMed
Metadata
Title
Urethral involvement in granulomatosis with polyangiitis: a case-based review
Authors
Hamdy M. A. Ahmed
Mohanad M. Elfishawi
Ahmed Hagiga
Ibrahim M. A. Ahmed
Ya Li Chen
Publication date
01-07-2019
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 7/2019
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-019-04331-7

Other articles of this Issue 7/2019

Rheumatology International 7/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.